biotech insider buying
biotech insider buying Articles
Insider buying surged in February. Warren Buffett continues to build a stake in a media stock, and initial and secondary offerings tempted other insiders.
Published:
With the earnings-reporting season underway, insider buying has been slow. Yet some return buyers continue to build stakes, including huge new purchases in the past week.
Published:
The number of notable insider purchases has slowed since the beginning of the year. Yet one huge buy in the past week stood out.
Published:
Berkshire Hathaway came back this past week to load up on one particular tech stock. Meanwhile, other insiders were acquiring shares of a pair of biotech stocks.
Published:
Warren Buffett has been trimming stakes lately. So it was a bit of a surprise to see three huge insider purchases from Berkshire Hathaway late last week.
Published:
The most notable insider purchases of stock in the past week were in biotech and energy companies, as well as a specialty retailer.
Published:
The past week brought some huge insider share purchases, including a contrarian buy at an e-commerce platform operator and another at a troubled satellite provider.
Published:
Warren Buffett again boosted his stake in the newly independent Sirius XM. A biotech IPO prompted huge insider buying as well.
Published:
Warren Buffett again boosted his stake in the newly independent Sirius XM. Biotech stocks continue to prompt notable insider buying as well.
Published:
Warren Buffett recently boosted his stake in the newly independent Sirius XM. Biotech initial public offerings in the past week also prompted some huge insider buying.
Published:
Public offerings of stock and activist investor activity prompted some huge insider buying at an entertainment company, an airline, biotechs, and more.
Published:
A public offering of shares this past week prompted a huge purchase from a beneficial owner. Meanwhile, a couple of repeat buyers further boosted their stakes as well.
Published:
IPOs at three biotechs last week tempted insiders to make huge purchases of shares. This effect spilled over into buying at a couple of other biotechs as well.
Published:
Though insider buying has slowed to a trickle in the past two weeks, two CEOs and two beneficial owners made notable purchases.
Published:
Top carmaker Stellantis boosted its stake in an aircraft maker last week, and biotech and energy stocks saw notable insider buying too.
Published:

Discover Our Top AI Stocks
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.